BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04123366-completion@plaintrial.com
DTSTAMP:20261028T000258Z
DTSTART;VALUE=DATE:20260723
SUMMARY:Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3
 475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) a
 nd/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (
 MK-7339-007/KEYLYNK-007) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04123366
URL:https://plaintrial.com/trial/NCT04123366
END:VEVENT
END:VCALENDAR